JPMorgan raised the firm’s price target on Syndax (SNDX) to $38 from $33 and keeps an Overweight rating on the shares. The firm updated models in the smid-cap biotechnology space.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter